once weekly glp 1 brand names Comparing Ozempic, Wegovy and Other GLP-1 Drugs How GLP-1 medications are transforming

This interaction could increase the risk of bleeding

Beyond weight: the indications race What should drug discovery watch in the GLP-1 pipeline

11 , e70076 (2025)

Pharmacotherapy Most patients will require oral hypoglycemic agents and/or insulin to control hyperglycemia, especially in advanced stages of liver disease

June 4, 2024 Update: The Judicial Panel on Multidistrict Litigation (JPML) has noted in its latest docket report that there are now 101 lawsuits currently filed against the makers of Ozempic and other GLP-1 agonist drugs in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation

All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work